Los Angeles, CA, April 09, 2026 (GLOBE NEWSWIRE) -- This report contains affiliate links. If a purchase is made through…
A single-dose of Trogenix’s proprietary Synthetic Super-Enhancers achieved complete tumour elimination in 83% of treated cases with no toxicity over…
Funding is awarded following successful completion of IND-enabling studies and clinical study authorization USD 6 million in additional funding to support…
Strengthens three community health models spanning community‑embedded care, earlier intervention and data‑driven population healthScales program footprint from 11 countries to…
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR…
April 08, 2026 03:00 ET | Source: Aravax MELBOURNE, Australia and OXFORD, United Kingdom, April 08, 2026 (GLOBE NEWSWIRE) --…
Novonesis expands global footprint with acquisition of production facility in Southeast Asia Investment of around USD 50 million strengthens fermentation capabilities…
GAITHERSBURG, Md., April 07, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a series of initiatives designed…
April 07, 2026 08:05 ET | Source: NextCure The U.S. Food and Drug Administration (FDA) has granted Fast Track designation…
April 07, 2026 08:00 ET | Source: Valitor, Inc. BERKELEY, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- Valitor, a biotechnology company…